Panteghini M
1st Laboratory of Clinical Chemistry, Spedali Civili, Brescia, Italy.
Eur Heart J. 1998 Nov;19 Suppl N:N8-11.
The field of biochemical markers of cardiac damage is in a dynamic state, with new applications continually appearing and new assays and markers being developed, but also with several analytical and interpretative problems to resolve. In this situation it is essential that a uniform and rigorous outlook be maintained to ensure optimal test utilization. For these reasons, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) agreed to establish a Committee on 'Standardization of Markers of Cardiac Damage' (C-SMCD). The first task of the C-SMCD concerns coordination of the different activities from affiliated associations, with (1) a review of documents and recommendations and (2) supervision and, possibly, the take-over of the standardization activities. Second, the C-SMCD supports development of scientific programmes for forthcoming international meetings and congresses. The third task of the C-SMCD is development of specific additional projects to promote the rational use of cardiac markers and to identify new areas of research.
心脏损伤生化标志物领域处于动态发展之中，新的应用不断涌现，新的检测方法和标志物也在不断研发，但同时也存在一些分析和解读方面的问题有待解决。在这种情况下，保持统一且严谨的观点以确保最佳的检测应用至关重要。出于这些原因，国际临床化学和检验医学联合会（IFCC）同意成立一个“心脏损伤标志物标准化委员会”（C-SMCD）。C-SMCD的首要任务涉及协调附属协会的不同活动，包括（1）审查文件和建议，以及（2）监督并可能接管标准化活动。其次，C-SMCD支持为即将召开的国际会议和大会制定科学计划。C-SMCD的第三项任务是开展特定的额外项目，以促进心脏标志物的合理使用并确定新的研究领域。
